Question 1

What’s the financial overview for Boston Scientific Corporation?

Accepted Answer

Boston Scientific Corporation’s market cap stands at $0.15 trillion right now. The company’s trailing twelve-month earnings per share EPS is $1.37, with a dividend yield of N/A%. Their next earnings report is set for January 29, 2025, and the estimated EPS for that period is $1.61. You can also check out summaries of their income statement, balance sheet, and cash flow details for a fuller picture of their financials.

Question 2

How can I analyze historical data?

Accepted Answer

To analyze historical data with AI tools, apply the date range filter above the table to focus on a specific period. The table displays daily open, high, low, close prices, and volume, enabling you to spot trends and patterns. Use these insights to make informed decisions based on historical performance.

Question 3

What does Boston Scientific Corporation Stock ROE tell us?

Accepted Answer

Boston Scientific Corporation stock ROE shows positive market sentiment. A higher ROE means the company’s management is doing a better job at using equity financing to drive income and growth. It’s a handy metric for comparing how a company stacks up against its competitors or the broader market.

Question 4

What do Analysts say about Boston Scientific Corporation?

Accepted Answer

18 number of Analysts recommended buying Boston Scientific Corporation the stock and 1 analysts recommended selling the stock.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024
Revenue	$4.66B	$4.56B	$4.21B	$4.12B
Cost of Revenue	$1.45B	$1.47B	$1.31B	$1.27B
Gross Profit	$3.21B	$3.10B	$2.90B	$2.85B
Gross Profit Ratio	$0.69	$0.68	$0.69	$0.69
R&D Expenses	$443.00M	$459.00M	$407.00M	$383.00M
SG&A Expenses	$1.60B	$1.61B	$1.56B	$1.45B
Operating Expenses	$2.29B	$2.42B	$2.16B	$2.33B
Total Costs & Expenses	$3.74B	$3.89B	$3.48B	$3.60B
Interest Income	$0.00	$0.00	$0.00	$0.00
Interest Expense	$82.00M	$80.00M	$79.00M	$77.00M
Depreciation & Amortization	$325.00M	$348.00M	$306.00M	$311.00M
EBITDA	$1.21B	$1.01B	$1.05B	$812.00M
EBITDA Ratio	$0.26	$0.22	$0.25	$0.20
Operating Income	$921.00M	$675.00M	$733.00M	$520.00M
Operating Income Ratio	$0.20	$0.15	$0.17	$0.13
Other Income/Expenses (Net)	-$116.00M	-$90.00M	-$64.00M	-$100.00M
Income Before Tax	$805.00M	$585.00M	$669.00M	$420.00M
Income Before Tax Ratio	$0.17	$0.13	$0.16	$0.10
Income Tax Expense	$133.00M	$23.00M	$200.00M	$98.00M
Net Income	$674.00M	$566.00M	$468.00M	$324.00M
Net Income Ratio	$0.14	$0.12	$0.11	$0.08
EPS	$0.46	$0.38	$0.32	$0.22
Diluted EPS	$0.45	$0.38	$0.32	$0.22
Weighted Avg Shares Outstanding	$1.48B	$1.47B	$1.47B	$1.47B
Weighted Avg Shares Outstanding (Diluted)	$1.49B	$1.49B	$1.49B	$1.48B

Boston Scientific Corporation